{"id":"22d40606-9170-4090-af70-dc468b592788","arxiv_id":"2508.20120","paper_version":1,"verdict":"CONDITIONAL","confidence":"MODERATE","novelty_score":4.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":3,"one_line_summary":"When citation counts are divided by funding, MIMIC outperforms UK Biobank, OpenSAFELY, and All of Us, which the authors attribute to its active data community model.","lead":"This paper compares citation counts for MIMIC, UK Biobank, OpenSAFELY, and All of Us, and finds that MIMIC produces far more citations per million dollars of funding. The authors argue that active data communities, not just open access, drive this efficiency and can make research more equitable.","discovery_kind":"extension","skeptic_critique":{"model":"deepseek-v4-flash","headline":"Causal attribution to 'data communities' is untested: no free-access, no-community comparator is included, so MIMIC's per-dollar advantage may reflect open access, dataset age, or ICU field rather than community engagement.","rationale":"The reader correctly flags the funding denominator as a threat to the per-dollar magnitude. I agree that the $14.4M NIH grant total may undercount institutional, hosting, and community costs, and this should be tested. However, even a large correction (up to an order of magnitude) would not erase MIMIC's qualitative per-dollar advantage because its reported funding is already 30-150x smaller than the comparators. The more decisive weakness is that the paper's central mechanism—'through accessible data communities'—is never identified in the data. The comparison varies multiple factors at once and explicitly excludes the best control (AmsterdamUMCdb). Thus the headline causal claim overreaches; at best the study supports a descriptive association. I therefore keep the reader's CONDITIONAL verdict: acceptance should be conditional on adding a community-free open-data comparator or on softening the causal language in the abstract and conclusion.","tokens_in":7892,"tokens_out":17564,"duration_ms":194212,"concrete_test":"Include AmsterdamUMCdb (or another free, de-identified ICU dataset without organized community engagement) in the same analysis over the same calendar window, using its documented startup and operating costs. Compute cumulative citations per $1M funding on the same matched-years basis. If AmsterdamUMCdb's citations-per-dollar is comparable to MIMIC's, the community mechanism is not supported; if it is substantially lower, the community explanation gains evidentiary weight.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim is that MIMIC's high citation impact per dollar arises 'through accessible data communities.' The study design cannot support this attribution. The four compared datasets differ simultaneously in access cost (free vs tiered fees), data domain (ICU vs general population vs COVID), dataset age (27 years vs 4-9 years), and community engagement. No dataset is both freely accessible and lacking an organized community, so the marginal effect of community is unidentified. The natural control, AmsterdamUMCdb (open de-identified ICU data without a comparable community), is explicitly excluded in §2 (Data Sources and Selection): 'Other similar datasets, such as AmsterdamUMCdb and HiRID, were excluded due to smaller cohorts and later publication date, limiting citation comparability.' As a result, MIMIC's higher citations-per-dollar could be driven entirely by open access, first-mover advantage in AI/ICU, or different citation norms in critical care, not by datathons or community infrastructure. The Discussion's claims about 'deliberate community cultivation' are therefore unsupported by the comparison; at most they are a post hoc interpretation.","agreement_with_reader":"partial"},"referee_report":{"model":"deepseek-v4-flash","summary":"The paper conducts a bibliometric comparison of the MIMIC dataset with UK Biobank, OpenSAFELY, and All of Us, using manually collected Google Scholar citation counts, a dataset h-index, and a funding-adjusted 'citations per $1 million' efficiency metric. It reports that MIMIC has higher citation impact per dollar than the comparators and attributes this to an 'accessible data community' model with datathons and open infrastructure. The manuscript includes a GitHub repository with data and code and is framed as evidence for investing in open clinical data communities.","tokens_in":8155,"tokens_out":6466,"duration_ms":74526,"significance":"If the causal attribution were valid, the paper would provide a strong argument for community-based open data infrastructure in clinical research. The raw citation data are collected and shared transparently, and the idea of normalizing citation impact by funding is a useful descriptive exercise. However, the central claim—that MIMIC's higher per-dollar impact arises through data communities—is not identified by the study design. The four datasets differ in domain, access cost, age, and community engagement simultaneously; the funding denominator for MIMIC is incomplete; and MIMIC citations are summed across multiple versions while the comparators are single papers. These issues are load-bearing, not cosmetic.","major_comments":[{"comment":"The causal attribution to 'data communities' is unsupported by the comparison. MIMIC differs from UK Biobank, OpenSAFELY, and All of Us in access cost, data domain, dataset age, and community infrastructure at the same time. No dataset is both freely accessible and lacking an organized community, so the marginal effect of community engagement is unidentified. The paper explicitly excludes AmsterdamUMCdb and HiRID in §2, including AmsterdamUMCdb, which is a freely accessible ICU dataset without a comparable datathon/community program. Without a free-access/no-community control or an alternative identification strategy, the Abstract's claim that MIMIC achieved higher impact 'through accessible data communities' is a post hoc interpretation, not a finding.","section":"§2 Data Sources and Selection; Abstract; Discussion"},{"comment":"The per-dollar efficiency result is directly determined by a manually assembled funding denominator. MIMIC's total funding is listed as $14,427,192 from NIH grants 2003–2023 only; this excludes institutional support, salaries, PhysioNet hosting costs, and non-NIH sources. Because the headline result is a ratio of citations to this figure, an incomplete denominator can change the ranking. The authors need a sensitivity analysis using alternative funding bounds—for example, adding PhysioNet operating costs, using total Laboratory for Computational Physiology budgets, or inflation-adjusting all grants—and reporting how the efficiency gap changes.","section":"§2 Data Retrieval; Table 1"},{"comment":"MIMIC citations are summed across the original publications for MIMIC-I, II, III, and IV, while UK Biobank, OpenSAFELY, and All of Us are each represented by one original paper. This makes the cumulative citation counts non-comparable. The paper states this was done because the versions come from the same research group, but the result is that the MIMIC total can include citations to four separate papers. A consistent comparison should use a single MIMIC release (e.g., MIMIC-III from 2016) or sum all relevant comparator publications over the same window.","section":"§2 Data Retrieval"},{"comment":"The efficiency comparison ignores the very different time spans and funding periods: MIMIC has 27 years of availability versus 4–9 years for the comparators, and the funding streams are from different eras without inflation adjustment. The manuscript acknowledges dataset heterogeneity and version bias in the limitations but does not flag the missing free-access/no-community control or the uncertainty in the funding denominator. These omissions are not optional caveats; they are central to the validity of the paper's conclusion.","section":"Results §3; Discussion §4 (Limitations)"}],"minor_comments":[{"comment":"The choice of an eight-year window for MIMIC because 'citations drop significantly since it does not include MIMIC-III anymore' is arbitrary and should be justified by a data-driven rule or replaced by a fixed same-length window for all datasets.","section":"§2 Data Retrieval"},{"comment":"The dataset h-index ranks papers that cite the dataset's original publication by their own citation counts. This measures the impact of the citing literature, not the dataset itself, and is not directly comparable across fields with different citation cultures. It should be de-emphasized or redefined.","section":"§2 H-index Calculation for datasets"},{"comment":"Funding figures are described only as 'manually compiled from publicly available sources.' The manuscript should provide a supplementary table with source URLs, access dates, and the exact grant entries for each dataset, including currency conversion rates for UK Biobank.","section":"Table 1"},{"comment":"The LMIC participation percentages (10.1% for MIMIC vs. 6.2% for UK Biobank) are cited from reference 4, not computed in this study. The text should clearly label them as prior published statistics rather than results of the present analysis.","section":"Discussion §4"},{"comment":"The ratio plots use a log-10 scale, which visually amplifies differences when the denominator is small. Since the MIMIC funding figure is the smallest and the least certain, the plots should include confidence intervals or a sensitivity band that reflects the uncertainty in the funding denominator.","section":"Figures 1b, 2b, 3b"}],"recommendation":"reject","confidential_remarks":"The authors include a co-author (LAC) who leads the MIT Critical Data community and is closely involved with MIMIC; the manuscript does not include a competing-interest statement for this relationship. Given the paper's strong endorsement of that community, the editor may wish to request a COI disclosure and a more cautious framing. The manuscript might be publishable as a descriptive bibliometric efficiency comparison if the causal claim is removed and the funding/citation-count issues are addressed, but the current central claim is not supported by the evidence."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"The paper does something concrete: it compiles Google Scholar citations for MIMIC, UK Biobank, OpenSAFELY, and All of Us, computes a dataset-level h-index, and reports citations per $1 million of funding. The code and data are on GitHub, and the authors openly list several limitations, including dataset heterogeneity and version bias. As a descriptive exercise, it is a reasonable starting point for conversations about open data and research impact.\n\nThe soft spots are real. The central per-dollar claim depends on a manually compiled funding figure for MIMIC of about $14.4 million, drawn from NIH grants only. That likely omits PhysioNet hosting, institutional support, and staff salaries, so the efficiency gap against UK Biobank and All of Us could narrow substantially if actual costs were counted. In addition, MIMIC citations sum across versions I–IV while comparators use a single paper, which inflates MIMIC's numbers. The eight-year window after MIMIC's first release is a post hoc choice, and the manual Google Scholar counts come with no uncertainty bounds. These are mechanical problems, not fatal ones, but they mean the efficiency ratios should be read as rough upper bounds.\n\nThe more serious issue is attribution. The abstract and discussion credit 'accessible data communities' for MIMIC's impact, but no comparator isolates community engagement. A dataset that is free and passively open, like AmsterdamUMCdb, is explicitly excluded for having a smaller cohort and later publication date. That exclusion is defensible for citation comparability, but it means the marginal effect of datathons and community infrastructure is not identified. MIMIC's high per-dollar citation count could just as easily reflect open access, first-mover advantage in ICU/AI research, or field-specific citation norms. The paper would be on firmer ground if it presented the community explanation as a hypothesis rather than a conclusion.\n\nAll that said, the paper is not incoherent. The methods are transparent, the limitations section shows honest engagement, and the descriptive snapshot is useful for policy discussions about data sharing. It is a plausible hypothesis-generating study, not a demonstrated causal result.\n\nI would not cite this in my own work, but I would bring it to a reading group as a case study in how bibliometric comparisons can overreach. It deserves peer review rather than desk rejection, with the expectation of substantial revision: either soften the causal language or add a control that separates free access from community engagement.","headline":"A useful descriptive comparison of four health data repositories, but the per-dollar efficiency headline rests on an incomplete funding denominator and the 'data community' attribution is untested.","tokens_in":8662,"tokens_out":1910,"would_cite":false,"duration_ms":24735,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"MIMIC, a low-cost open clinical dataset, produces far more citation impact per dollar than far more expensive controlled-access repositories, the paper claims.","keywords":["data communities","MIMIC","open clinical data","bibliometrics","dataset h-index","funding efficiency","data sharing","health equity"],"falsifier":"Independently audit MIMIC's full cost base—including MIT Laboratory for Computational Physiology salaries, PhysioNet hosting, infrastructure, and administrative overhead—and recompute citations per $1 million. Given the reported 452 citations per $1 million for MIMIC versus 14 for UK Biobank, a true total cost above roughly $465 million would eliminate the advantage over UK Biobank.","tokens_in":7830,"feed_emoji":"📊","tokens_out":4522,"duration_ms":47828,"temperature":0.7,"pith_summary":"This paper tries to establish that the way a medical dataset is shared and cultivated matters as much as its size or cost. Comparing MIMIC—an open intensive-care dataset run through PhysioNet and the MIT Critical Data community—with UK Biobank, OpenSAFELY, and All of Us, the authors find that MIMIC, funded at about $14.4 million, generates more citations per dollar than comparators costing tens of millions to billions. They attribute the gap to an \"accessible data community\" model: free de-identified data, shared code, datathons, and deliberate outreach that draws in researchers from low- and middle-income countries. If the claim holds, modest investments in community-building around open clinical data could yield outsized research return and broader participation.","feed_headline":"Low-cost MIMIC out-cites billion-dollar biobanks per dollar","feed_subtitle":"A $14M open dataset yields more citations per million than UK Biobank, OpenSAFELY, and All of Us.","key_machinery":"The comparison rests on three linked measures: cumulative citation counts gathered from Google Scholar for each dataset's original publication; a dataset h-index, defined as the largest h such that h papers citing the dataset each have at least h citations; and a funding-efficiency ratio that divides citations or h-index by every $1 million of compiled public funding. MIMIC's funding total of $14,427,192 is the pivotal denominator; the ratio turns small absolute impact advantages into large efficiency gaps.","core_discovery":"The central claim is that MIMIC, despite limited funding, delivers higher impact per dollar spent through accessible data communities. Using Google Scholar citations, a dataset-level h-index, and funding-adjusted citation counts, the authors report that MIMIC accumulates more citations per $1 million than UK Biobank, OpenSAFELY, or All of Us, and that its papers are more equitably distributed, with about 10.1% of publications from low- and middle-income countries. The paper argues the mechanism is not the data alone but the community around it—datathons, open code, transparent credentialing—which lowers barriers to entry and sustains a productive research ecosystem.","pith_inferences":["The paper leaves implicit that its efficiency result is only as strong as the funding denominator: if MIMIC's true cost includes unreported MIT salaries, PhysioNet hosting, or in-kind support, the per-dollar advantage over larger repositories shrinks.","A sharper test of the \"community, not just openness\" mechanism would compare MIMIC with a similarly cheap but passively shared ICU dataset, holding data type and cost constant.","Citation efficiency measures scientific output, not clinical adoption; a community model could also be judged by downstream uses such as regulatory approvals, clinical deployments, or policy changes, which bibliometrics do not capture.","The approach could be extended to other emerging open health datasets once enough publication years accumulate, converting this single comparison into a generalizable benchmark."],"forward_implications":["If the cost-efficiency claim is right, funding agencies should treat community engagement as a core component of data infrastructure, not an optional add-on.","Open, low-cost datasets with active communities could be a higher-return route to clinical AI research than exclusive biobanks, especially for institutions with limited resources.","Policies that reward data sharing and community cultivation may widen participation: MIMIC-related work draws about 10.1% of its publications from low- and middle-income countries, versus 6.2% for UK Biobank.","The dataset-level h-index and citations-per-dollar metrics offer a simple, reusable standard for future repository evaluations."],"supporting_citations":[{"why":"Defines the first MIMIC version, the starting point for MIMIC citation totals.","marker":"[8]"},{"why":"Defines MIMIC-II, contributing to the summed MIMIC citations.","marker":"[9]"},{"why":"Original MIMIC-III paper whose Google Scholar 'Cited by' count feeds the analysis.","marker":"[10]"},{"why":"MIMIC-IV paper, also supplying citation counts and patient cohort size.","marker":"[11]"},{"why":"UK Biobank's original publication, the comparator's citation baseline.","marker":"[12]"},{"why":"OpenSAFELY's main COVID-19 publication, its citation source.","marker":"[13]"},{"why":"All of Us original publication, the comparator's citation baseline.","marker":"[14]"},{"why":"Source for the 10.1% low- and middle-income country and 6.2% UK Biobank participation figures used in the equity argument.","marker":"[4]"}],"fun_headline_variants":["Community, not cash, drives MIMIC's impact per dollar","MIMIC's open community outshines billion-dollar biobanks","Small dataset, big reach: the power of data communities","Data communities beat big budgets in research impact","Why MIMIC's $14M beats biobanks' billions in citations"],"cache_read_input_tokens":2688,"weakest_assumption_plain":"The result assumes that MIMIC's complete cost is captured by the $14,427,192 in NIH grant funding the authors manually totaled; unreported institutional support or hosting costs could erase the efficiency gap.","fun_headline_variants_meta":{"raw":{"variants":["Community, not cash, drives MIMIC's impact per dollar","MIMIC's open community outshines billion-dollar biobanks","Small dataset, big reach: the power of data communities","Data communities beat big budgets in research impact","Why MIMIC's $14M beats biobanks' billions in citations"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000142,"raw_usage":{"total_tokens":918,"prompt_tokens":573,"completion_tokens":345,"prompt_tokens_details":{"cached_tokens":256},"prompt_cache_hit_tokens":256,"prompt_cache_miss_tokens":317,"completion_tokens_details":{"reasoning_tokens":257}},"tokens_in":317,"tokens_out":345,"duration_ms":4772,"temperature":1.0,"reasoning_tokens":257,"cache_read_input_tokens":256,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-05T17:16:37.230638+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Independently audit MIMIC's full cost base—including MIT Laboratory for Computational Physiology salaries, PhysioNet hosting, infrastructure, and administrative overhead—and recompute citations per $1 million. Given the reported 452 citations per $1 million for MIMIC versus 14 for UK Biobank, a true total cost above roughly $465 million would eliminate the advantage over UK Biobank.","supporting_citations":[{"cited_title":"C., Rutter, J","cited_arxiv_id":null,"evidence_quote":"All of Us original publication, the comparator's citation baseline."},{"cited_title":"J., Walker, A","cited_arxiv_id":null,"evidence_quote":"OpenSAFELY's main COVID-19 publication, its citation source."},{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"Defines the first MIMIC version, the starting point for MIMIC citation totals."},{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"Original MIMIC-III paper whose Google Scholar 'Cited by' count feeds the analysis."},{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"MIMIC-IV paper, also supplying citation counts and patient cohort size."},{"cited_title":"& Collins, R","cited_arxiv_id":null,"evidence_quote":"UK Biobank's original publication, the comparator's citation baseline."},{"cited_title":"A., Cobanaj, M., Eber, R., Fiske, A., Gallifant, J., Li, C., Lingamallu, G., Petushkov, A","cited_arxiv_id":null,"evidence_quote":"Source for the 10.1% low- and middle-income country and 6.2% UK Biobank participation figures used in the equity argument."}],"review_version":1}